Diagnosis of polymyalgia rheumatica usually means a favourable outcome for your patient

Indian J Med Res. 2017 May;145(5):593-600. doi: 10.4103/ijmr.IJMR_298_17.

Abstract

Polymyalgia rheumatica (PMR) is a unique disease of elderly people, traditionally diagnosed based on a clinical picture. A typical case is a combination of severe musculoskeletal symptoms and systemic inflammatory response with spectacular response to corticosteroids treatment. The severity of symptoms may be surprising in older patients where immunosenescence is normally expected. However, PMR may be diagnosed in haste if there is a temptation to use this diagnosis as a shortcut to achieve rapid therapeutic success. Overdiagnosis of PMR may cause more problems compared to underdiagnosis. The 2012 PMR criteria proposed by European League against Rheumatism/American College of Rheumatology aim to minimize the role of clinical intuition and build on more objective features. However, questions arise if this is possible in PMR. This has been discussed in this review.

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Aged
  • Giant Cell Arteritis / pathology
  • Humans
  • Inflammation / diagnosis*
  • Inflammation / epidemiology
  • Inflammation / pathology
  • Medical Overuse*
  • Polymyalgia Rheumatica / diagnosis*
  • Polymyalgia Rheumatica / epidemiology
  • Polymyalgia Rheumatica / pathology
  • Severity of Illness Index

Substances

  • Adrenal Cortex Hormones